Atlas Trials

Study to Assess the Design of Use of REKOVELLE® in Women Undergoing In Vitro Fertilisation or Intracytoplasmic Sperm Injection Procedures in Routine Clinical Practice

Clinical trial NCT04503707 · COMPLETED

Trial details

NCT number
NCT04503707
Sponsor
Ferring Pharmaceuticals
Status
COMPLETED
Study type
OBSERVATIONAL
Controlled Ovarian Stimulation
Start date
2020-06-17
Primary completion
2021-10-31
Enrollment
250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.